Unjha Formulations Ltd.
Snapshot View

View in App

Prices View details >>

12.90 +0.25 ▲2.0%

21 March 2023, 04:01:00 PM
Volume: 96

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unjhaformulations.com
Market Cap 5.78 Cr.
Enterprise Value(EV) 3.73 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.98 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 13.23 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 5.96 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.16 Calculated using Price: 12.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.45 Cr. 4,480,500 Shares
FaceValue 10
Company Profile
Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.98%
1 Week
-10.42%
1 Month
-8.51%
3 Month
-23.44%
6 Month
+30.30%
1 Year
+27.72%
2 Year
+53.57%
5 Year
-4.09%
10 Year
+268.57%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 244.18 89.75 52.48 31.18 24.22 18.57 5.55 12.35
Return on Capital Employed (%) 68.66 73.70 67.61 32.15 25.41 25.57 26.80 21.13
Return on Assets (%) 3.84 4.92 8.26 8.82 6.79 7.89 8.37 2.86 7.23

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 0 0 1 1 1 2 2 2 2 3
Non Curr. Liab. 0
Curr. Liab. 4 3 2 3 3 2 2 2 1 2
Minority Int.
Equity & Liab. 4 3 3 4 4 4 4 4 3 4
Non Curr. Assets 1 1 1 1 1 1 1 1 1 1
Curr. Assets 2 2 2 2 3 3 3 2 2 3
Misc. Exp. not W/O 0 0 0 0 0
Total Assets 4 3 3 4 4 4 4 4 3 4

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 7 9 10 12 11 11 11 10 14 15
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 9 10 12 11 12 11 10 14 15
Total Expenditure -6 -9 -10 -12 -11 -11 -10 -10 -14 -14
PBIDT 0 0 0 0 0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 1 1 1 1 1 0 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 -1 0 0 0 0 0 -1 0
Cash Fr. Inv. 0 0 0 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 -1 0
Cash & Cash Eqvt 0 1 0 0 0 0 1 1 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92
Public 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 20 Mar 2023
Board Meeting Intimation for Sub: Board Meeting - Date: 27.03.2023
UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2023 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Obligation and Disclosure Requirement) Regulations 2015.
Wed, 15 Mar 2023
Sub : Change In Promoter'S Share-Holding Due To Death
Ref : Refer Corporate Announcement Dated 13 /03/2023
Wed, 15 Mar 2023
Sub: Disclosure Under Regulation 10( 6) R/W Regu.10(G) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011{' Takeover Regulations'}
Regulation 10( 6) r/w Regu.10(g) SAST REGULATIONS 2011

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,419.30 -0.5%
Divi's Laboratories Ltd. 73,553.38 2,773.45 -0.9%
Cipla Ltd. 69,632.88 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,378.30 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 26.39 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 3.07 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Unjha Formulations Ltd.

What is Unjha Formulations share price?
Can I buy Unjha Formulations shares now?
What is the Market Cap of Unjha Formulations?
What are the key metrics to analyse Unjha Formulations?
What is the 52 Week High and Low of Unjha Formulations?
What is the trend of Unjha Formulations share price?